Arcus Biosciences (RCUS) Non-Current Deffered Revenue (2017 - 2026)
Arcus Biosciences (RCUS) recorded Non-Current Deffered Revenue of $37 million in Q2 2026, down 38.3% from $60 million a year earlier and down 17.8% from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends
At the end of FY2025, Arcus Biosciences reported Non-Current Deffered Revenue of $43 million, down 81.6% from FY2024.
- Annual Non-Current Deffered Revenue has declined for four straight years, with a five-year compound annual growth rate of -20.2% (FY2020 to FY2025).
- Across earlier years, Non-Current Deffered Revenue came in at $234 million in FY2024 (-23.8%), $307 million in FY2023 (-13.5%), $355 million in FY2022 (-23.2%) and $462 million in FY2021 (+248.6%).
- The Q2 2026 figure is the lowest quarterly Non-Current Deffered Revenue since Q2 2020.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for 15 consecutive quarters, with an average decline of 49.7% over the last eight quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 313.2% in Q2 2022, against a decline of 81.7% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $45 million (Q1 2026), $43 million (Q4 2025) and $53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Arcus Biosciences | 3.28 Bn | -53.05 Mn | - | 37.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.00 Mn |
| Mar 31, 2026 | 45.00 Mn |
| Dec 31, 2025 | 43.00 Mn |
| Sep 30, 2025 | 53.00 Mn |
| Jun 30, 2025 | 60.00 Mn |
| Mar 31, 2025 | 219.00 Mn |
| Dec 31, 2024 | 234.00 Mn |
| Sep 30, 2024 | 289.00 Mn |
| Jun 30, 2024 | 214.00 Mn |
| Mar 31, 2024 | 242.00 Mn |
| Dec 31, 2023 | 307.00 Mn |
| Sep 30, 2023 | 326.00 Mn |
| Jun 30, 2023 | 330.00 Mn |
| Mar 31, 2023 | 330.00 Mn |
| Dec 31, 2022 | 355.00 Mn |
| Sep 30, 2022 | 382.58 Mn |
| Jun 30, 2022 | 429.34 Mn |
| Mar 31, 2022 | 456.91 Mn |
| Dec 31, 2021 | 462.00 Mn |
| Sep 30, 2021 | 94.68 Mn |
API Access
Arcus Biosciences Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();